In vitro expansion of CD34+CD38− cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

In vitro expansion of CD34+CD38− cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia

Published:2014-08-08 Issue:3 Volume:29 Page:606-614
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sakashita K,Kato I,Daifu T,Saida S,Hiramatsu H,Nishinaka Y,Ebihara Y,Ma F,Matsuda K,Saito S,Hirabayashi K,Kurata T,Uyen L T N,Nakazawa Y,Tsuji K,Heike T,Nakahata T,Koike K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014239.pdf

Reference18 articles.

1. Koike K, Matsuda K . Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008; 141: 567–575.

2. Loh ML . Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol 2011; 152: 677–687.

3. Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 2013; 45: 937–941.

4. Sawai N, Koike K, Higuchi T, Ogami K, Oda M . Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia. Blood 1998; 91: 4065–4073.

5. Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N et al. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 1996; 88: 2655–2664.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia;Biochemical Pharmacology;2023-07

2. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?;Pediatric Blood & Cancer;2022-09-12

3. Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research;Cells;2021-09-06

4. Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells;Gene Therapy;2021-08-13

5. Investigation of patient factors associated with the number of transfusions required during chemotherapy for high‐risk neuroblastoma;Vox Sanguinis;2021-07